Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised controlled open-label trial of TPF induction chemotherapy in the surgical management of locally advanced head and neck cancer
2010-023195-22Phase 3Completed
- Sponsor
- University of Liverpool
- Start
- Apr 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel, cisplatin and fluorouracil in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by University of Liverpool. Primary endpoint: Feasibility of recruitment into the TITAN trial. Started Apr 2011; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2010-023195-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023195-22.